Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium is a genus of unicellular eukaryotic parasites responsible for causing malaria. These obligate intracellular parasites have a complex life cycle involving both vertebrate hosts (humans, other mammals, birds, reptiles) and mosquito vectors (Anopheles spp.). Key pathogenic mechanisms include red blood cell invasion and replication, antigenic variation to evade host immunity, and disruption of host cell function. Several species infect humans, with P. falciparum being the most deadly. The apicoplast, a nonphotosynthetic plastid, is an essential organelle and an important drug target.
Varies depending on the specific drug; includes inhibition of parasite metabolism, disruption of hemoglobin digestion, and targeting of essential organelles like the apicoplast.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium species.